RankAlpha logo
Back to Rankings

GRFS

GrifolsD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
GRFS vs peer average
28/100
GRFS vs. peer average (D vs. C)
Grade spread
A 2 · B 2 · C 1 · D 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

IMVT is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $6.35B

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerIMVTImmunovant
GRFS
Grifols
IMVT
Immunovant
Grade
D
A
Momentum
23
87
Value
70
41
Sentiment
-
66
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs IMVT

GRFS / IMVT
Grade Position
Below peers
GRFS vs. peer average (D vs. C)
28/100
Momentum
23
IMVT
Value
70
GRFS
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs GRFS
1
IMVT
Immunovant Inc Common
A
100/100
-3
2
LEGN
Legend Biotech Corp ADR
C
60/100
-1
3
CNTA
Centessa Pharmaceuticals PLC ADR
B
80/100
-2
4
AVTR
Avantor Inc Common
D
40/100
Even
5
RGEN
Repligen Corp Common
D
40/100
Even
IMVT is the first peer returned for this comparison set.